Clinical Trial

REal-life ON PARKinson's - ITaly (REONPARK-IT)

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The present study aims to evaluate the effectiveness and safety of opicapone in a real-world setting at centers for Parkinson's disease located in Italy.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-07-14
Trial Details
NCT Number NCT07403799
Lead Sponsor Bial - Portela C S.A.
Conditions Parkinson Disease
Enrollment 200 participants
Start Date 2025-07-08
Primary Completion 2028-10-31 (estimated)
Study Completion 2029-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-13